Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Tinea Infections, Cutaneous, Emergency Medicine


Basics


Description


  • Superficial fungal infections of the hair, skin, or nails:
    • Usually confined to the stratum corneum layer
    • Among the most common diseases worldwide
  • Requires keratin for growth, so does not involve mucosa
  • Named for location of infection

Etiology


  • Dermatophytes:
    • Microsporum
    • Trichophyton
    • Epidermophyton
    • Malassezia furfur, a yeast, is the etiologic agent of tinea versicolor (not a true tinea)
  • Trauma or maceration of the skin may allow fungal entry into skin
  • Transmission may be person to person, animal to person, or soil to person

  • Fungi can be spread from toys and brushes
  • Tinea unguium is rare in children and is associated with:
    • Down syndrome
    • Immunosuppression
    • Tinea pedis or capitis

Diagnosis


Signs and Symptoms


  • Tinea capitis:
    • Children are predominately affected
    • Most contagious dermatophytosis
    • Alopecia, dandruff-like scaling
    • Kerion:
      • Boggy, inflammatory mass that exudes pus and causes cervical lymphadenopathy
    • "Black dots "  from infected hairs broken off at the scalp
  • Tinea corporis ( "ringworm " ):
    • Arms, legs, and trunk
    • Sharply marginated, annular lesion with raised margins and central clearing
    • Hair follicle involvement may produce indurated papules and pustules
    • Lesions may be single, multiple, or concentric
    • Pets are often a vector
  • Tinea cruris ( "jock itch " ):
    • Erythematous, scaly, marginated patches involving the perineum, thighs, and buttocks
    • Associated with heat, humidity, and tight-fitting undergarments
    • Unlike the case in candidiasis, the scrotum and penis are spared
  • Tinea pedis ( "athletes foot " ):
    • Scaling, maceration, fissuring between the toes
    • Risk factors:
      • Advanced age
      • Immunocompromised status
      • Hot, humid climates
      • Infrequent changing of socks
    • More common in adults than children
    • Most common tinea infection in US
    • "Trichophytid "  reaction:
      • Vesicular eruption remote from infection
      • Involving hands, mimics dyshidrotic eczema
  • Tinea unguium:
    • 1 type of onychomycosis
    • Yellow or brown discoloration with thickening and debris under the nails
    • Onycholysis: Loosening of the nail from bed
    • May involve the plantar surface of the foot
  • Tinea versicolor (not true tinea):
    • Most common in warm months
    • Round or oval superficial brown, yellow, or hypopigmented macules that may coalesce
    • Upper trunk, arms, and neck
    • Facial involvement is common in children

History
  • Time of onset from inoculation to visible skin changes is about 2 wk
  • Main symptom is itching:
    • Hair loss with tinea capitis
  • Participation in contact sports or contacts with similar skin disease

Physical Exam
  • Tinea capitis: Alopecia, broken hairs at scalp surface
  • Tinea corporis: Areas of exposed skin typically involved with annular scaly plaques, raised edges, may have pustules and vesicles
  • Tinea cruris: Erythematous lesions on groin and pubic region with central clearing and raised edges
  • Tinea pedis: Scaling, maceration, and fissuring of toe webs, often only 1 foot affected
  • Tinea unguium: Separation of nail plate from nail bed with thickened, discolored, broken nails

Essential Workup


  • Diagnose by clinical exam
  • If diagnosis is in doubt, confirm with microscopy before starting oral antifungals because of possible side effects

Diagnosis Tests & Interpretation


Lab
Fungal cultures are slow growing and should not be routinely done ‚  
Imaging
Generally not indicated ‚  
Diagnostic Procedures/Surgery
  • Wood lamp is insensitive:
    • Trichophyton, the most common cause of tinea infections, does NOT fluoresce
    • Microsporum fluoresces bright green
    • Malassezia (tinea versicolor) fluoresces yellow to yellow-green
    • Erythrasma (nontinea corynebacterial infection) will fluoresce coral red
  • Microscopy:
    • Cleanse area with 70% ethanol
    • Scrape active margin of lesion with no. 10 or no. 15 scalpel blades
    • Place scrapings on a glass slide, add a drop of 10 " “20% potassium hydroxide solution, and cover with a coverslip
    • The presence of septate hyphae confirms dermatophyte infection
    • Budding yeasts and short hyphae ( "spaghetti and meatballs " ) confirms Malassezia

  • Methods to obtain fungal elements for culture or microscopy:
    • Brushing the hair with a toothbrush
    • Rolling a moistened cotton swab
    • Collecting skin cells with transparent tape

Differential Diagnosis


  • Tinea capitis: Impetigo, pediculosis, alopecia areata, seborrheic dermatitis, atopic dermatitis, and psoriasis
  • Tinea corporis: Impetigo, herpes simplex, Lyme disease, verruca vulgaris, psoriasis, nummular eczema, granuloma annulare, herald patch of pityriasis rosea, erythema multiforme, urticaria, seborrheic dermatitis, and secondary syphilis
  • Tinea cruris: Impetigo, seborrheic dermatitis, psoriasis, candidal infection, irritant and allergic contact dermatitis, and erythrasma
  • Tinea pedis: Scabies, erythrasma, Candida, allergic and contact dermatitis, and psoriasis
  • Tinea unguium: Psoriasis, dermatitis, lichen planus, and congenital nail dystrophy
  • Tinea versicolor: Vitiligo, secondary syphilis

Treatment


Pre-Hospital


Maintain universal precautions. ‚  

Initial Stabilization/Therapy


Only in immunocompromised or septic patients ‚  

Ed Treatment/Procedures


  • Improvement usually occurs within 1 " “2 wk of treatment; hair and nail tinea require longer treatment of 3 " “6 mo
  • Topical antifungals do not penetrate hair/nails:
    • Use in conjunction with systemic agent for tinea capitis or unguium.
  • Tinea capitis:
    • Terbinafine is now considered the drug of choice by most:
      • Pill form may be crushed in food
    • Newer oral antifungals, including terbinafine, itraconazole, and fluconazole, are preferred:
      • Retained in tissues longer
      • Allows for shorter treatment courses without a decrease in efficacy
      • Improved compliance
    • Selenium sulfide or ketoconazole shampoo reduces transmissibility
    • Kerion may respond more rapidly with addition of prednisone (peds: 1 mg/kg PO QD for 2 wk)

Terbinafine may be less effective than griseofulvin against Microsporum species causing tinea capitis; however, Trichophyton species are the predominant causative organism in children: ‚  
  • Tinea corporis, cruris, and pedis:
    • Topical terbinafine or imidazoles (ketoconazole, miconazole, and clotrimazole) are 1st-line agents:
      • Topical terbinafine has been shown to be as effective as or more effective than the imidazoles, with a shorter course
    • Oral therapy may be necessary for cases resistant to topical treatment or for immunocompromised patients
    • Keep the area dry (talc powders) and frequently change socks and underclothes
  • Tinea unguium:
    • Requires oral therapy and longer course than other tinea infections
    • Terbinafine had a slightly higher cure rate than imidazoles (ketoconazole, miconazole, and clotrimazole) or griseofulvin in a meta-analysis
    • Ciclopirox 8% nail lacquer approved for treatment but has low cure rates:
      • May enhance oral therapy
  • Tinea versicolor:
    • Topicals are 1st-line therapy:
      • Selenium sulfide 2.5% shampoo was as effective as topical ketoconazole
    • Oral ketoconazole, itraconazole, or fluconazole have been used with cure rates up to 97% but are not as safe as topicals

Medication


  • Ciclopirox 8% nail lacquer: Apply to the affected nails daily, max. 48 wk; remove with alcohol every 7 days (peds: Same).
  • Clotrimazole: Apply 1% cream to affected area BID for 4 " “6 wk (peds: Same).
  • Fluconazole: Tinea unguium " ”150 " “300 mg/wk pulse therapy for 3 " “6 mo for fingernails, 6 " “12 mo for toenails; tinea corporis, cruris, and pedis: 150 mg PO weekly for 4 " “6 wk; tinea versicolor: 400 mg PO single dose (peds: 6 mg/kg/d for 3 " “6 wk for tinea capitis)
  • Griseofulvin: Tinea capitis, corporis, cruris " ”500 mg PO QD for 4 " “6 wk (peds: 10 " “20 mg/kg up to 500 mg PO QD until the hair regrows, usually 6 " “8 wk)
  • Itraconazole: Tinea capitis: Adults and peds: 3 " “5 mg/kg PO QD for 2 " “4 wk; tinea unguium: 200 mg PO QD for 3 mo; tinea versicolor: 400 mg PO QD for 3 " “7 days; contraindicated in CHF
  • Ketoconazole: 2% topical cream QD for 4 " “6 wk; tinea capitis, corporis, cruris, pedis " ”200 mg PO QD for 4 wk (peds: 3.3 " “6.6 mg/kg PO QD for 4 wk); tinea versicolor " ”400 mg PO ƒ —1 or 200 mg QD for 7 days (contraindicated with terfenadine and astemizole); soda increases absorption 65%
  • Miconazole: Apply cream to affected area BID for 4 " “6 wk (peds: Same)
  • Selenium sulfide: 2.5% shampoo to affected area for 10 min for 1 " “2 wk (peds: Same)
  • Terbinafine: 1% topical cream BID
    for 4 " “6 wk for tinea pedis QD for tinea corporis and tinea cruris; tinea unguium " ”250 mg PO QD for 6 wk for fingernails, 12 wk for toenails (peds: <20 kg,
    67.5 mg/d; 20 " “40 kg, 125 mg/d; >40 kg, 250 mg/d at same interval as adult); tinea pedis: 250 mg PO per day for 2 wk; tinea capitis: 250 mg/d for 4
    wk (dose by weight as for tinea unguium for 4 wk)
  • Tolnaftate: Apply 1% cream/powder/solution to the affected area BID for 4 " “6 wk (peds: Same)

  • The oral antifungals may rarely cause hepatotoxicity; consider checking liver transaminases prior to initiating therapy

Topical preparations are preferred when possible ‚  
  • Few studies addressing the use of antifungal medications during pregnancy in humans
  • Some of the imidazoles have shown adverse effects in animals " “ class C (fluconazole, itraconazole, ketoconazole)
  • Clotrimazole, miconazole, and terbinafine are class B drugs
  • Weigh risk: Benefit as elective antifungal therapy generally not recommended.

First Line
  • Tinea capitis: Terbinafine
  • Tinea corporis, cruris, pedis: Topical terbinafine or imidazoles (ketoconazole, miconazole, and clotrimazole)
  • Tinea versicolor: Selenium sulfide shampoo and topical ketoconazole

Follow-Up


Disposition


Admission Criteria
  • Invasive disease in immunocompromised host
  • Kerion with secondary bacterial infection

Discharge Criteria
  • Most patients may be managed as outpatients
  • Children may return to school once appropriate treatment has been initiated

Issues for Referral
Patients started on oral antifungals should be referred for follow-up to monitor therapy and advised regarding symptoms of hepatitis ‚  

Follow-Up Recommendations


  • Monitor for bacterial superinfection, cellulitis, generalized invasive infection:
    • Especially in immunocompromised (diabetics, HIV patients)

Pearls and Pitfalls


  • Tinea capitis is the most common pediatric dermatophyte infection
  • Itching is the main symptom in most forms of tinea, with associated hair loss in tinea capitis
  • Cellulitis frequently complicates of tinea pedis
  • Relapse of tinea pedis/cruris is common
    • Patients should wash or replace contaminated socks/towels/footwear

Additional Reading


  • Gonz ƒ ‘lez ‚  U, Seaton ‚  T, Bergus ‚  G, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev.  2007;(4):CD004685.
  • Kelly ‚  BP. Superficial fungal infections. Pediatr Rev.  2012;33:e22 " “e37.
  • Moriarty ‚  B, Hay ‚  R, Morris-Jones ‚  R. The diagnosis and management of tinea. BMJ.  2012;345:e4380.
  • Rashid ‚  RM, Miller ‚  AC, Silverberg, ‚  MA. Tinea in Emergency Medicine. May 9, 2011. http://emedicine.medscape.com/article/787217-overview.
  • Zhang ‚  AY, Camp ‚  WL, Elewski ‚  BE. Advances in topical and systemic antifungals. Dermatol Clin.  2007;25:165 " “183.

Codes


ICD9


  • 110.0 Dermatophytosis of scalp and beard
  • 110.1 Dermatophytosis of nail
  • 110.5 Dermatophytosis of the body
  • 110.3 Dermatophytosis of groin and perianal area
  • 110.2 Dermatophytosis of hand
  • 110.4 Dermatophytosis of foot

ICD10


  • B35.0 Tinea barbae and tinea capitis
  • B35.1 Tinea unguium
  • B35.4 Tinea corporis
  • B35.6 Tinea cruris
  • B35.2 Tinea manuum
  • B35.3 Tinea pedis

SNOMED


  • 5441008 Tinea capitis (disorder)
  • 84849002 Tinea corporis (disorder)
  • 402134005 Onychomycosis due to dermatophyte (disorder)
  • 399029005 Tinea cruris (disorder)
  • 48971001 Tinea manus (disorder)
  • 6020002 Tinea pedis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer